Tele: 561.316.3330
Breaking Medical Device News

Friday, October 15, 2021
HomeHOSPITALSPulsed Field Ablation: Andrea Natale, MD Participates in Clinical Trial to Evaluate...

Pulsed Field Ablation: Andrea Natale, MD Participates in Clinical Trial to Evaluate Safety and Efficacy of a New Cardiac-Specific Catheter

February 12, 2021

Pulsed field ablation is a new approach to treating patients with atrial fibrillation (A Fib). Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center (TCAI), recently participated in the first-in-human trials of this catheter in Europe.

Pulse field ablation uses a controlled electric field instead of thermal energy to ablate or burn cardiac tissue during simple and complex ablation procedures through a process known as irreversible electroporation (IRE). This technique may prevent collateral damage to surrounding tissue during ablation.

“The process of irreversible electroporation is an exciting new approach in our field, as it may reduce the risk of complications such as pulmonary stenosis (narrowing of an artery) or esophageal fistulas (abnormal connections between the esophagus and heart). While rare, esophageal fistulas can be life-threatening,” Dr. Natale said. “This treatment may also reduce or eliminate chest pain that often occurs following surgery, as well as result in a shorter recovery.”

Physicians will test the catheter on approximately 40 patients in Europe, with in-human trials expected in the U.S. this summer.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy